the optimal sequencing of novel therapies in mantle cell lymphoma
Published 2 years ago • 173 plays • Length 2:09Download video MP4
Download video MP3
Similar videos
-
0:57
novel therapeutic strategies in all
-
2:49
insights into the role of novel btkis in the treatment landscape of r/r cll
-
1:17
novel biomarkers and emerging therapies for sickle cell disease
-
1:16
how novel immunotherapies have impacted the treatment of r/r all
-
1:41
novel therapies for high-risk mds
-
0:42
the limited access to novel therapeutics for sickle cell disease in lmics
-
1:32
shifting the treatment landscape of itp: novel agents and future outlooks
-
4:20
therapy-related all: etiology, prognosis, and treatment
-
6:23
voxelotor in sickle cell disease
-
2:50
cutaneous t-cell lymphoma - yale medicine explains
-
6:41
factors associated with successful tfr in patients with cml who have discontinued tki therapy
-
2:33
the effect of lymphodepleting agents on rate and severity of toxicities following car-t infusion
-
2:00
novel treatment strategies for patients with cml who are intolerant or resistant to available tkis
-
2:05
novel therapies on the horizon for cutaneous t-cell lymphoma
-
1:38
navigating reimbursement for patients receiving novel therapies in argentina
-
2:30
cellular therapy and sct in synergy
-
1:46
towards a personalized treatment approach for scd
-
2:34
the burden of vte in cancer patients: impacts and novel treatments
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
3:59
current therapeutic management strategies in sickle cell disease
-
2:10
driving the identification of novel t cell therapies
-
3:17
pre-mds states: novel therapeutic approaches, and determining appropriate trial endpoints